NCM
Nantahala Capital Management Portfolio holdings
AUM
$1.68B
1-Year Est. Return
115.06%
This Fund
S&P 500
1 Year Est. Return
+115.06%
AUM
$1.68B
AUM Growth
+$58.5M
(+3.6%)
Holding
160
Top Buys
| 1 | +$49.8M | |
| 2 | +$28.8M | |
| 3 | +$27.8M | |
| 4 |
Soleno Therapeutics
SLNO
|
+$24.7M |
| 5 |
Peloton Interactive
PTON
|
+$15.7M |
Top Sells
| 1 | +$59.5M | |
| 2 | +$44.1M | |
| 3 | +$35.3M | |
| 4 |
Amneal Pharmaceuticals
AMRX
|
+$20.3M |
| 5 |
IMAX
IMAX
|
+$18.1M |
Sector Composition
| 1 | Healthcare | 62.18% |
| 2 | Consumer Discretionary | 15.78% |
| 3 | Financials | 6.34% |
| 4 | Communication Services | 5.5% |
| 5 | Industrials | 2.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
The Bancorp
TBBK
$2.25B
| $72.4M | 4.31% |
1,071,685
+219,351
|
|
||
2
Establishment Labs
ESTA
$1.95B
| $72M | 4.29% |
987,689
-985,803
|
|
||
3
Hilton Grand Vacations
HGV
$3.44B
| $69.9M | 4.17% |
1,561,622
-106,131
|
|
||
|
4
Soleno Therapeutics
SLNO
$2.18B
| $60.8M | 3.63% |
1,314,002
+450,239
|
|
||
5
Xtant Medical Holdings
XTNT
$86.5M
| $53.6M | 3.2% |
68,394,000
|
|
||
6
Fulcrum Therapeutics
FULC
$533M
| $48.6M | 2.89% |
4,293,346
-377,438
|
|
||
7
Bioventus
BVS
$593M
| $45M | 2.68% |
6,047,403
+236,741
|
|
||
8
Savara
SVRA
$1.14B
| $44.3M | 2.64% |
7,344,783
-1,430,592
|
|
||
9
Evolus
EOLS
$342M
| $38.7M | 2.31% |
5,820,649
+93,792
|
|
||
10
Fox Factory Holding Corp
FOXF
$683M
| $37.4M | 2.23% |
2,188,300
+1,459,652
|
|
||
|
11
Peloton Interactive
PTON
$1.58B
| $36.5M | 2.18% |
5,932,676
+2,234,976
|
|
||
12
Gogo Inc
GOGO
$624M
| $31.7M | 1.89% |
+6,792,649
|
|
||
13
Tango Therapeutics
TNGX
$2.22B
| $31.7M | 1.89% |
3,572,633
+1,762,685
|
|
||
|
14
Amneal Pharmaceuticals
AMRX
$4.2B
| $30.8M | 1.84% |
2,447,516
-1,777,048
|
|
||
15
Eventbrite
EB
$453M
| $30.5M | 1.82% |
6,854,718
+23,323
|
|
||
16
iShares Russell 2000 ETF
IWM
$71.3B
| $28.8M | 1.72% |
+117,159
|
|
||
17
Abeona Therapeutics
ABEO
$279M
| $26.2M | 1.56% |
4,963,052
+398,387
|
|
||
|
RAPT
18
DELISTED
RAPT Therapeutics
RAPT
| $25.5M | 1.52% |
754,153
+130,871
|
|
||
19
Fractyl Health
GUTS
$74.6M
| $23.9M | 1.42% |
10,846,440
-1,290,477
|
|
||
20
Avalo Therapeutics
AVTX
$313M
| $22.4M | 1.34% |
1,235,000
|
|
||
|
ABVX
21
Abivax
ABVX
$9.12B
| $20.7M | 1.23% |
153,235
-404,329
|
|
||
22
Eton Pharmaceutcials
ETON
$467M
| $19.9M | 1.19% |
1,175,951
|
|
||
23
Globus Medical
GMED
$11.7B
| $19.6M | 1.17% |
224,962
-75,038
|
|
||
24
ADC Therapeutics
ADCT
$595M
| $19.3M | 1.15% |
5,475,433
+3,209,144
|
|
||
25
Fossil Group
FOSL
$227M
| $19M | 1.14% |
5,064,359
+1,323,202
|
|